Objective: Primary tumors of the trachea are extremely rare. Treatment methods vary considerably and few studies have sought to provide adequate guidelines. This study reviews the records of patients treated for tracheal cancer at the Tata Memorial Hospital (TMH), Mumbai, India. Subjects and Methods: Fifteen patients with primary tracheal malignancies were identified in the TMH database during the period from 1983 to 2000. They were predominantly males (87%) belonging to an older age-group (67% above 40 years). Common presenting symptoms were cough, hoarseness, hemoptysis and indications of airway obstruction. Squamous cell carcinoma was the commonest histologic subtype (40%) followed by adenoid cystic carcinoma (27%). Ten patients received radical treatment. One patient underwent surgery (resection and anastomosis) and received postoperative radiotherapy. Another was explored but was found to be unresectable and was 1 of 2 patients treated with chemotherapy and radiotherapy. Laser resections and radiotherapy were used in 2 patients while 4 patients were managed with radiotherapy alone. One patient was treated elsewhere. The majority of patients (8/9) were treated with locoregional fields and doses ranging from 40 to 60 Gy (median 50 Gy). Two patients also received intraluminal brachytherapy, 1 as part of initial treatment and another for recurrence. Results: Only 5 patients treated at TMH (5/9) achieved local control of their disease. Follow-up times ranged from 1 month to 134 months, median of 38 months. Distant metastases were identified in 4 patients (bone n = 1 and lung n = 3). Median survival was 38 months. Overall survival at 5 years was 37% by Kaplan-Meier method, but this figure should be treated with caution since only 6 patients had a follow-up of more than 2 years. Conclusion: Tracheal cancer is a rare malignancy. Radiation therapy is a reasonably effective modality for unresectable disease.
© 2004 S. Karger AG, Basel
- Malignant tracheal tumors
- Howard DJ, Haribhakti VV: Primary tumors of the trachea: Analysis of clinical features and treatment results. J Laryngol Otol 1994;108:230–232.
- Young JL, Percy CL, Asire AJ, Berg JW, Cusano MM, Gloeckler LA, Horm JW, Lourie WI, Pollack ES, Shambaugh EM: Cancer incidence and mortality in the United States, 1973–77. Natl Cancer Inst Monogr 1981;57:1–187.
- Manninen MP, Antila PJ, Pukander JS, Karma PH: Occurrence of tracheal carcinoma in Finland. Acta Otolaryngol 1991;111:1162–1169.
- Hajdu SI, Huvos AG, Goodner JT, Foote FW, Bealtice EJ: Carcinoma of the trachea: Clinico-pathologic study of 41 cases. Cancer 1970;25:1448–1456.
- McCafferty GJ, Parker LS, Suggit SC: Primary malignant disease of the trachea. J Laryngol 1964;78:441–479.
- Grillo HC: Tracheal surgery. Scand J Thorac Cardiovasc Surg 1983;17:67–77.
- Fields JN, Rigaud G, Emami BN: Primary tumors of the trachea: Results of radiation therapy. Cancer 1989;63:2429–2433.
- Chow DC, Komaki R, Libshitz HI, Mountain CF, Ellerbroeck N: Treatment of primary neoplasms of the trachea – the role of radiation therapy. Cancer 1993;71:2946–2952.
- Licht PB, Friis S, Pettersson G: Tracheal cancer in Denmark: A nationwide study. Eur J Cardiothorac Surg 2001;19:339–345.
- Grillo HC, Mathisen BJ: Primary tracheal tumors: Treatment and results. Ann Thorac Surg 1990;49:69–77.
- Cheung AY: Radiotherapy for primary carcinoma of the trachea. Radiother Oncol 1989;14:279–285.
- Mark EJ: Pathology of tracheal neoplasms; in Choi NC, Grillo HC (eds): Thoracic Oncology, pp 257–269. New York, Raven Press, 1983.
- Grillo HC: Management of tumors of the trachea; in Thawley SE, Panje WR (eds): Comprehensive Management of Head and Neck Tumors. Philadelphia, Saunders, 1987, pp 1686–1702.
- Chao MW, Smith JG, Laidlaw C, Joon DL, Ball D: Results of treating primary tumors of the trachea with radiotherapy. Int J Radiat Oncol Biol Phys 1998;41:779–785.
- Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S: Radiotherapy for primary squamous cell carcinoma of the trachea. Radiother Oncol 1996;41:135–138.
- Mornex F, Coquard R, Danhier S, Maingon P, El Husseini G, Van Houtte P: Role of radiotherapy in the treatment of primary tracheal carcinoma. Int J Radiat Oncol Biol Phys 1998;41:299–305.
- Birt D: The management of malignant tracheal neoplasms. J Laryngol Otol 1963;84:723–731.
- Baraka ME: Malignant tumors of the trachea. Ann R Coll Surg Engl 1984;66:27–29.
- Khan FM: The Physics of Radiation Therapy, ed 2. Baltimore, Williams & Wilkins, 1994, p 299.
- Rostom AY, Morgan RL: Results of treating primary tumors of the trachea by irradiation. Thorax 1978;33:387–393.
- Makarewicz R, Mross M: Radiation therapy alone in the treatment of tumours of the trachea. Lung Cancer 1998;20:169–174.
- Percaprio B, Price JC, Murphy P: Endotracheal irradiation of adenoid cystic carcinoma of the trachea. Radiology 1978;128:209–210.
- Boedker A, Hald A, Kristensen D: A method for selective endobronchial and endotracheal irradiation. J Thorac Cardiovasc Surg 1982;84:59–61.
- Harms W, Latz D, Becker H, Herth F, Schraube P, Krempien R, Wannenmacher M: HDR-brachytherapy boost for residual tumour after external beam radiotherapy in patients with tracheal malignancies. Radiother Oncol 1999;52:251–255.
- Shraube P, Latz D, Wannenmacher M: Treatment of primary squamous cell carcinoma of the trachea: The role of radiation therapy. Radiother Oncol 1994;33:254–258.
Dr. Ziad S. Thotathil
PO Box 39433
73055 Nuzha (Kuwait)
Tel. +965 796 0199, Fax +965 481 3724
Received: September 28, 2002
Revised: April 26, 2003
Number of Print Pages : 5
Number of Figures : 1, Number of Tables : 2, Number of References : 25
Medical Principles and Practice
A Publication of the Academic Publications Council
Vol. 13, No. 2, Year 2004 (Cover Date: March-April 2004)
Journal Editor: Farida Al Awadi, Kuwait
ISSN: 1011–7571 (print), 1423–0151 (Online)
For additional information: http://www.karger.com/mpp
Open Access License / Drug Dosage / Disclaimer
Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license
), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.